Eurepa (Repaglinide) 0.5mg – 100 tablet

Name: Eurepa (Repaglinide) 0.5mg - 100 tablet
SKU: 0ceb940ea364
Availability: InStock

USD $63.92

Each Eurepa contains .5 mg Repaglinide 100 tablets. Used to treat diabetic adults who suffer from Diabetes Mellitus type 2 diabetes.

ATC Classification: A10BX02
Active Ingrediant: Repaglinide
Generic Name: Eurepa
Manufacturer: Torrent
Strength: 0.5mg
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 30 TABLET

Important update for customers in the USA:

Most of the World has stopped all packages mailing to the USA due to De Minimus Exemption.

The only or best option right now is trans shipment to the USA, we are holding India post and express mail shipments until India sets up a taxation / tariff collection system on our side which they say can take 1 month or longer.
We ship normally to the UK, AUS, Japan, and most others. The situation only involves the USA.
For people who have placed an order for express mail we will ship this out once India mail is open or you can contact us to make arrangements to ship through Trans Shipping and pay the tariff and shipping costs this way.
We are very sorry for this, the USA policy shift came fast, without rules or regulations, and not understanding of what other countries should do.
As things develop we will adjust our shipping prices and operations to best service you.

Thanks for your patience.

Torrent Pharma

Use

Diabetes mellitus, type 2:?To improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise

Medication Safety Issues

Sound-alike/look-alike issues:

Prandin may be confused with Avandia

Repaglinide may be confused with rasagiline

Storage/Stability

Store at 20?C to 25?C (68?F to 77?F). Protect from moisture.

Adverse Reactions

>10%:

Central nervous system: Headache (9% to 11%)

Endocrine & metabolic: Hypoglycemia (16% to 31%)

Respiratory: Upper respiratory tract infection (10% to 16%)

1% to 10%:

Cardiovascular: Ischemia (4%), chest pain (2% to 3%)

Gastrointestinal: Diarrhea (4% to 5%), constipation (2% to 3%)

Genitourinary: Urinary tract infection (2% to 3%)

Hypersensitivity: Hypersensitivity reaction (1% to 2%)

Neuromuscular & skeletal: Back pain (5% to 6%), arthralgia (3% to 6%)

Respiratory: Sinusitis (3% to 6%), bronchitis (2% to 6%)

<1%, postmarketing, and/or case reports: Alopecia, anaphylactoid reaction, blurred vision (transient), cardiac arrhythmia, ECG abnormality, hemolytic anemia, hepatic insufficiency (severe), hepatitis, hypertension, increased liver enzymes, jaundice, leukopenia, myocardial infarction, palpitations, pancreatitis, Stevens-Johnson syndrome, thrombocytopenia, visual disturbance (transient)

Additional information

Active Ingrediant	Repaglinide
Generic Name	Eurepa
Alternate Names	Dexanorm, Diarol, Dibetix, Enyglid, Enyglide, Eurepa, Fulaidi, Glimet, Hipover, Ilgaper, Magicnorm, Nomopil, NovoNorm, Paglimide, Posprand, Prandin, Pranstad, Rapilin, Reglin, Reglinide, Relinide, Reodon, Repa, Repaglid, Repaglinide, Repanorm, Ripalid, Rosemond, Sestrine, Supernide, Surepost
Strength	0.5 mg
Dosage Type	Tablet
Packaging Type	Foil in Box

Eurepa (Repaglinide) 0.5mg – 100 tablet